We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$194M
Cap. Flow
+$40.5M
Cap. Flow %
2.24%
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74

Top Buys

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$32.5M
2
AMAT icon
Applied Materials
AMAT
+$26.5M
3
AAPL icon
Apple
AAPL
+$13.7M
4
MSFT icon
Microsoft
MSFT
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$9.49M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.3M
2
BEKE icon
KE Holdings
BEKE
+$13.2M
3
TSM icon
TSMC
TSM
+$13.2M
4
ASX icon
ASE Group
ASX
+$7.59M
5
IQ icon
iQIYI
IQ
+$6.13M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.73%
2 Technology 31.74%
3 Communication Services 9.52%
4 Healthcare 5.08%
5 Financials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
226
Dyne Therapeutics
DYN
$4.68B
$312K 0.02%
8,829
-7,446
-46% -$216K
TWST icon
227
Twist Bioscience
TWST
$8.87B
$309K 0.02%
6,261
-5,274
-46% -$215K
NTAP icon
228
NetApp
NTAP
$36.7B
$308K 0.02%
+2,391
New +$268K
CRNX icon
229
Crinetics Pharmaceuticals
CRNX
$9B
$305K 0.02%
6,813
-3,435
-34% -$159K
CSGP icon
230
CoStar Group
CSGP
$13.1B
$304K 0.02%
4,095
+76
+2% +$6.44K
ACAD icon
231
Acadia Pharmaceuticals
ACAD
$5.02B
$301K 0.02%
18,528
+40
+0.2% +$646
BMY icon
232
Bristol-Myers Squibb
BMY
$136B
$299K 0.02%
7,190
+840
+13% +$37.6K
XEL icon
233
Xcel Energy
XEL
$47.8B
$298K 0.02%
5,585
+106
+2% +$5.77K
NUVL
234
DELISTED
Nuvalent
NUVL
$298K 0.02%
3,929
-1,207
-24% -$85.9K
ZTS icon
235
Zoetis
ZTS
$32B
$293K 0.02%
1,689
+24
+1% +$3.99K
ARDX icon
236
Ardelyx
ARDX
$984M
$289K 0.02%
39,033
-10,835
-22% -$76.2K
ACLX
237
DELISTED
Arcellx
ACLX
$288K 0.02%
5,212
-774
-13% -$42.1K
WDC icon
238
Western Digital
WDC
$166B
$287K 0.02%
+5,005
New +$278K
CCEP icon
239
Coca-Cola Europacific Partners
CCEP
$48.2B
$286K 0.02%
3,922
+101
+3% +$7.27K
MCK icon
240
McKesson
MCK
$104B
$284K 0.02%
487
-51
-9% -$28.4K
NTLA icon
241
Intellia Therapeutics
NTLA
$1.8B
$283K 0.02%
12,665
-1,795
-12% -$42.7K
CVS icon
242
CVS Health
CVS
$119B
$279K 0.02%
4,722
+467
+11% +$29.2K
FSLR icon
243
First Solar
FSLR
$22B
$278K 0.02%
+1,232
New +$269K
FOLD
244
DELISTED
Amicus Therapeutics
FOLD
$275K 0.02%
27,734
-7,498
-21% -$77K
KEYS icon
245
Keysight
KEYS
$54.5B
$274K 0.02%
2,001
+572
+40% +$83.6K
BDX icon
246
Becton Dickinson
BDX
$51.6B
$272K 0.02%
1,165
-12
-1% -$2.83K
RNAM
247
DELISTED
Avidity Biosciences
RNAM
$271K 0.02%
6,640
-2,857
-30% -$82K
CLDX icon
248
Celldex Therapeutics
CLDX
$3.07B
$269K 0.01%
7,258
-1,788
-20% -$67.5K
TER icon
249
Teradyne
TER
$55.5B
$268K 0.01%
+1,809
New +$230K
VERA icon
250
Vera Therapeutics
VERA
$2.46B
$268K 0.01%
7,395
-865
-10% -$34.3K

Similar funds

E Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
  • E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
  • E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
  • E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
  • E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
  • E Fund Management opened 24 new positions and closed 74 in Q2 2024.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.